» Articles » PMID: 34350706

H2A.B is a Cancer/testis Factor Involved in the Activation of Ribosome Biogenesis in Hodgkin Lymphoma

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2021 Aug 5
PMID 34350706
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Testis-specific regulators of chromatin function are commonly ectopically expressed in human cancers, but their roles are poorly understood. Examination of 81 primary Hodgkin lymphoma (HL) samples showed that the ectopic expression of the eutherian testis-specific histone variant H2A.B is an inherent feature of HL. In experiments using two HL cell lines derived from different subtypes of HL, H2A.B knockdown inhibited cell proliferation. H2A.B was enriched in both nucleoli of these HL cell lines and primary HL samples. We found that H2A.B enhanced ribosomal DNA (rDNA) transcription, was enriched at the rDNA promoter and transcribed regions, and interacted with RNA Pol I. Depletion of H2A.B caused the loss of RNA Pol I from rDNA chromatin. Remarkably, H2A.B was also required for high levels of ribosomal protein gene expression being located at the transcriptional start site and within the gene body. H2A.B knockdown reduced gene body chromatin accessibility of active RNA Pol II genes concurrent with a decrease in transcription. Taken together, our data show that in HL H2A.B has acquired a new function, the ability to increase ribosome biogenesis.

Citing Articles

The Function of H2A Histone Variants and Their Roles in Diseases.

Yin X, Zeng D, Liao Y, Tang C, Li Y Biomolecules. 2024; 14(8).

PMID: 39199381 PMC: 11352661. DOI: 10.3390/biom14080993.


Multifunctional histone variants in genome function.

Wong L, Tremethick D Nat Rev Genet. 2024; 26(2):82-104.

PMID: 39138293 DOI: 10.1038/s41576-024-00759-1.


HIST3H2A promotes the progression of prostate cancer through inhibiting cell necroptosis.

Yang L, Ruan Y, Xu H BMC Cancer. 2024; 24(1):544.

PMID: 38684944 PMC: 11059659. DOI: 10.1186/s12885-024-12308-4.


Roles of Histone H2A Variants in Cancer Development, Prognosis, and Treatment.

Lai P, Chan K Int J Mol Sci. 2024; 25(6).

PMID: 38542118 PMC: 10969971. DOI: 10.3390/ijms25063144.


Imaging analysis of six human histone H1 variants reveals universal enrichment of H1.2, H1.3, and H1.5 at the nuclear periphery and nucleolar H1X presence.

Salinas-Pena M, Rebollo E, Jordan A Elife. 2024; 12.

PMID: 38530350 PMC: 10965224. DOI: 10.7554/eLife.91306.


References
1.
Chew G, Bleakley M, Bradley R, Malik H, Henikoff S, Molaro A . Short H2A histone variants are expressed in cancer. Nat Commun. 2021; 12(1):490. PMC: 7817690. DOI: 10.1038/s41467-020-20707-x. View

2.
Ferreira R, Schneekloth Jr J, Panov K, Hannan K, Hannan R . Targeting the RNA Polymerase I Transcription for Cancer Therapy Comes of Age. Cells. 2020; 9(2). PMC: 7072222. DOI: 10.3390/cells9020266. View

3.
Roux K, Kim D, Burke B . BioID: a screen for protein-protein interactions. Curr Protoc Protein Sci. 2014; 74:19.23.1-19.23.14. DOI: 10.1002/0471140864.ps1923s74. View

4.
Mamaev N, Medvedeva N, Shust V, Markochev A, PASTERNAK N . Nucleoli and AgNORs in Hodgkin's disease. Mol Pathol. 1997; 50(3):149-52. PMC: 379610. DOI: 10.1136/mp.50.3.149. View

5.
Kamakaka R, Biggins S . Histone variants: deviants?. Genes Dev. 2005; 19(3):295-310. DOI: 10.1101/gad.1272805. View